Cognitive-Behavioral Management of Drug-Resistant Major Depressive Disorder

Giovanni A. Fava, Gianni Savron, Silvana Grandi, and Chiara Rafanelli

Published: June 15, 1997

Article Abstract

Background: The application of cognitive-behavioral treatment to drug-resistant major depression has received little research attention.

Method: Nineteen patients who failed to respond to at least two trials of antidepressant drugs of adequate dosages and duration were treated by cognitive-behavioral methods in an open trial.

Results: Three patients dropped out of treatment. The remaining 16 patients displayed a significant (p

Conclusion: These preliminary results suggest that a trial of cognitive-behavioral therapy by an experienced therapist should be performed before labeling an episode of major depression as “refractory” or “treatment resistant.” These latter terms should apply only when a psychotherapeutic effort has been made. Until then, it seems more appropriate to define depression as “drug refractory” or “drug treatment resistant.”

Volume: 58

Quick Links: Cognition , Neurologic and Neurocognitive

Continue Reading…

Subscribe to read the entire article


Buy this Article as a PDF


Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...